Grant: Planning and Dissemination Grant - Institute Community Support

Background: The Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) collaboration is a pan-Canadian team of researchers, clinicians, decision-makers, and others committed to establishing a framework for the use of real-world evidence (RWE) in cancer drug funding decisions. With a view to build capacity within the collaboration and widen our stakeholder reach, we have been holding in-person meetings in satellite to the Canadian Centre for Applied Research in Cancer Control (ARCC) annual conference. The prairie region of Canada, including Manitoba, Saskatchewan, and Alberta, is a region where CanREValue has identified a need to build further capacity and broaden engagement regarding the potential use of RWE in Canadian cancer drug funding decisions. In support of this goal, we will be hosting a "Developing a national Real-World Evidence decision making framework" interactive workshop in Saskatoon, Saskatchewan, which will be held as a satellite meeting to the 2020 ARCC Conference (May 25-26, 2020). Objective: The goal of the "Developing a national Real-World Evidence decision making framework" workshop is to engage national and local stakeholders to provide feedback regarding the CanREValue draft framework for the use of RWE in Canadian cancer drug funding decisions, focusing especially on stakeholders without previous involvement with CanREValue. Approach: The established core CanREValue team will lead the workshop, and the format will consist of presentations, group deliberations, and breakout sessions. Outcomes: Following the workshop CanREValue will have stakeholder feedback to inform and refine the draft framework to a version more ready for system implementation. We further anticipate an increase in CanREValue collaboration within the prairies, as well as the direct development of new collaborations between existing CanREValue members and invited participants.